|
|
NOXPRIN |
20 |
40 |
60 |
80 |
|
Sodium Enoxaparine |
20.00 mg |
40,00 mg |
60,00 mg |
80,00 mg |
|
Water c.s.p. |
0,20 ml |
0,40 ml |
0,60 ml |
0,80 ml |
Indications:
Prophylaxis of deep venous thrombosis leading to pulmonary embolism in patients undergoing:
Abdominal surgery
Hip replacement surgery, during and after hospitalization
Knee replacement surgery
Patients at risk of thrombotic complications due to reduced mobility during acute illness
Prophylaxis of ischemic complication in unstable angina and myocardial non Q infarction along with the administration of AAS
Inpatients with deep venous thrombosis with or without pulmonary embolism, along with warfarin.
Outpatients with deep venous thrombosis without pulmonary embolism, along with warfarin.
Contraindications:
NOXPRIN is contraindicated in patients with important active hemorrhage, with thrombocytopenia associated with in vitro test of platelets antibodies or in patients with hypersensitivity.
Patients with known hypersensitivity to heparin or products derivate from pigs, should not be treated with Noxprin or any other heparin.
Presentation:
NOXPRIN 20mg: Box containing 10 prefilled syringes with 0,20ml.
NOXPRIN 40mg Box containing 10 prefilled syringes with 0,40ml.
NOXPRIN 60mg: Box containing 10 prefilled syringes with 0,60ml.
NOXPRIN 80mg: Box containing 10 prefilled syringes with 0,80ml. |
